Insmed Incorporated (INSM)
NASDAQ·Healthcare·Biotechnology
$98.28
+1.64%
Mkt Cap $20.41B
Analyst Ratings
Buy
30
Hold
1
Sell
0
Price Target (56 analysts)
$216.39
Range $166.00 – $269.00
Implied Upside
+120.2%
Consensus $216.39 vs current $98.28
NASDAQ·Healthcare·Biotechnology
$98.28
+1.64%
Mkt Cap $20.41B
Buy
30
Hold
1
Sell
0
Price Target (56 analysts)
$216.39
Range $166.00 – $269.00
+120.2%
Consensus $216.39 vs current $98.28